Spire Wealth Management’s Verrica Pharmaceuticals VRCA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-568
| Closed | -$2.5K | – | 2580 |
|
|
2025
Q1 | $2.5K | Buy |
568
+3
| +0.5% | +$13 | ﹤0.01% | 2234 |
|
|
2024
Q4 | $3.96K | Hold |
565
| – | – | ﹤0.01% | 2107 |
|
|
2024
Q3 | $8.19K | Hold |
565
| – | – | ﹤0.01% | 1693 |
|
|
2024
Q2 | $41.2K | Hold |
565
| – | – | ﹤0.01% | 1180 |
|
|
2024
Q1 | $33.4K | Hold |
565
| – | – | ﹤0.01% | 1352 |
|
|
2023
Q4 | $33.4K | Buy |
565
+78
| +16% | +$4.61K | ﹤0.01% | 1340 |
|
|
2023
Q3 | $18.9K | Buy |
487
+104
| +27% | +$4.04K | ﹤0.01% | 1527 |
|
|
2023
Q2 | $22.1K | Hold |
383
| – | – | ﹤0.01% | 1554 |
|
|
2023
Q1 | $24.9K | Hold |
383
| – | – | ﹤0.01% | 1530 |
|
|
2022
Q4 | $11K | Buy |
+383
| New | +$11K | ﹤0.01% | 1588 |
|
|
2022
Q3 | – | Sell |
-383
| Closed | -$7K | – | 2618 |
|
|
2022
Q2 | $7K | Hold |
383
| – | – | ﹤0.01% | 2050 |
|
|
2022
Q1 | $31K | Hold |
383
| – | – | ﹤0.01% | 1635 |
|
|
2021
Q4 | $35K | Hold |
383
| – | – | ﹤0.01% | 1893 |
|
|
2021
Q3 | $48K | Buy |
383
+30
| +8% | +$3.76K | ﹤0.01% | 1495 |
|
|
2021
Q2 | $40K | Hold |
353
| – | – | ﹤0.01% | 1584 |
|
|
2021
Q1 | $53K | Buy |
+353
| New | +$53K | ﹤0.01% | 1699 |
|